Cargando…

Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry study

BACKGROUND: Clinical guidelines advise osimertinib as preferred first line treatment for advanced epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer (NSCLC) with deletions in exon 19 (del19) or exon 21 L858R mutation. However, for first-line osimertinib the real world overall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gijtenbeek, Rolof G.P., Damhuis, Ronald A.M., van der Wekken, Anthonie J., Hendriks, Lizza E.L., Groen, Harry J.M., van Geffen, Wouter H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932646/ https://www.ncbi.nlm.nih.gov/pubmed/36817181 http://dx.doi.org/10.1016/j.lanepe.2023.100592

Ejemplares similares

Prognostic Implication of KRAS G12C Mutation in a Real-World KRAS-Mutated Stage IV NSCLC Cohort Treated With Immunotherapy in The Netherlands
por: Noordhof, Anneloes L., et al.
Publicado: (2023)

Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) versus intercalated TKI with chemotherapy for EGFR-mutated nonsmall cell lung cancer
por: Gijtenbeek, Rolof G.P., et al.
Publicado: (2022)

ERS International Congress 2022: highlights from the Thoracic Oncology Assembly
por: Catarata, Maria Joana, et al.
Publicado: (2023)

A Nationwide Study on the Impact of Routine Testing for EGFR Mutations in Advanced NSCLC Reveals Distinct Survival Patterns Based on EGFR Mutation Subclasses
por: Koopman, Bart, et al.
Publicado: (2021)

Clinical Value of EGFR Copy Number Gain Determined by Amplicon-Based Targeted Next Generation Sequencing in Patients with EGFR-Mutated NSCLC
por: Wei, Jiacong, et al.
Publicado: (2021)

Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations
por: Koopman, Bart, et al.
Publicado: (2020)

The electronic nose: emerging biomarkers in lung cancer diagnostics
por: van Geffen, Wouter H., et al.
Publicado: (2019)

Response to HER2 Inhibition in a Patient With Brain Metastasis With EGFR TKI Acquired Resistance and an HER2 Amplification
por: Meedendorp, Arenda D., et al.
Publicado: (2018)

Determinants of COVID-19 vaccine uptake in the Netherlands: A nationwide registry-based study
por: Pijpers, J, et al.
Publicado: (2023)

Determinants of COVID-19 Vaccine Uptake in The Netherlands: A Nationwide Registry-Based Study
por: Pijpers, Joyce, et al.
Publicado: (2023)

CX Chemokine Receptor 7 Contributes to Survival of KRAS-Mutant Non-Small Cell Lung Cancer upon Loss of Epidermal Growth Factor Receptor
por: Liu, Bin, et al.
Publicado: (2019)

Prevalence and Hospital Admissions in Patients With Osteogenesis Imperfecta in The Netherlands: A Nationwide Registry Study
por: Storoni, Silvia, et al.
Publicado: (2022)

Data-driven development of the nationwide hip fracture registry in the Netherlands
por: Würdemann, Franka S., et al.
Publicado: (2022)

Reporting of Incidence and Outcome of Bone Metastases in Clinical Trials Enrolling Patients with Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma—A Systematic Review
por: Brouns, Anita, et al.
Publicado: (2021)

Stargardt disease: monitoring incidence and diagnostic trends in the Netherlands using a nationwide disease registry
por: Runhart, Esmee H., et al.
Publicado: (2021)

NL-EVDR: Netherlands—ExtraVascular Device Registry
por: Tjong, Fleur V. Y., et al.
Publicado: (2023)

The Netherlands Arrhythmogenic Cardiomyopathy Registry: design and status update
por: Bosman, L. P., et al.
Publicado: (2019)

Prognosis of patients with dementia: results from a prospective nationwide registry linkage study in the Netherlands
por: van de Vorst, Irene E, et al.
Publicado: (2015)

Static and dynamic hyperinflation during severe acute exacerbations of chronic obstructive pulmonary disease
por: van Geffen, Wouter H, et al.
Publicado: (2018)

Incidence and demographics of giant cell tumor of bone in The Netherlands: First nationwide Pathology Registry Study
por: Verschoor, Arie J, et al.
Publicado: (2018)

Mutations in EMT-Related Genes in ALK Positive Crizotinib Resistant Non-Small Cell Lung Cancers
por: Wei, Jiacong, et al.
Publicado: (2018)

Nationwide registry-based ecological analysis of Q fever incidence and pregnancy outcome during an outbreak in the Netherlands
por: de Lange, Marit M A, et al.
Publicado: (2015)

Central nervous system metastases and oligoprogression during treatment with tyrosine kinase inhibitors in oncogene-addicted non-small cell lung cancer: how to treat and when?
por: Schoenmaekers, Janna Josephus Anna Oda, et al.
Publicado: (2020)

Malignant Peritoneal Mesothelioma: Patterns of Care and Survival in the Netherlands: A Population-Based Study
por: de Boer, Nadine L., et al.
Publicado: (2019)

The Presence of EGFR T790M in TKI-Naïve Lung Cancer Samples of Patients Who Developed a T790M-Positive Relapse on First or Second Generation TKI Is Rare
por: Li, Weiting, et al.
Publicado: (2022)

Adherence to Oseltamivir Guidelines during Influenza Pandemic, the Netherlands
por: Fietjé, Esther H., et al.
Publicado: (2012)

Chronic Obstructive Pulmonary Disease Is Not Associated with KRAS Mutations in Non-Small Cell Lung Cancer
por: Saber, Ali, et al.
Publicado: (2016)

Incidence and outcomes of chronic total occlusion percutaneous coronary intervention in the Netherlands: data from a nationwide registry
por: van Veelen, A., et al.
Publicado: (2020)

Ethnic differences in colon cancer care in the Netherlands: a nationwide registry-based study
por: Lamkaddem, M., et al.
Publicado: (2017)

The role of AIP variants in pituitary adenomas and concomitant thyroid carcinomas in the Netherlands: a nationwide pathology registry (PALGA) study
por: Coopmans, E. C., et al.
Publicado: (2020)

Epidemiology of burn patients admitted in the Netherlands: a nationwide registry study investigating incidence rates and hospital admission from 2014 to 2018
por: Van Yperen, Daan T., et al.
Publicado: (2021)

Pharmacokinetically‐guided dosing to improve the efficacy of brigatinib in non‐small cell lung cancer patients
por: Koele, Simon E., et al.
Publicado: (2021)

Genomic Aberrations in Crizotinib Resistant Lung Adenocarcinoma Samples Identified by Transcriptome Sequencing
por: Saber, Ali, et al.
Publicado: (2016)

Pomalidomide in Patients With Relapsed and/or Refractory Multiple Myeloma: A Prospective Study Within the Nationwide Netherlands Cancer Registry
por: Wester, Ruth, et al.
Publicado: (2022)

Data quality and auditing within the Netherlands Heart Registration: using the PCI registry as an example
por: Houterman, S., et al.
Publicado: (2023)

Epidermal growth factor receptor tyrosine kinase inhibitors
por: Ranson, M
Publicado: (2004)

An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer Patients
por: Wei, Jiacong, et al.
Publicado: (2020)

Targeted therapies for unresectable stage III non-small cell lung cancer
por: Remon, Jordi, et al.
Publicado: (2021)

Adrenocortical Carcinoma Treatment in the Netherlands: An Analysis From the Netherlands Cancer Registry From 2014 to 2019
por: Steenaard, Rebecca, et al.
Publicado: (2021)

Ascertainment of cancer in longitudinal research: The concordance between the Rotterdam Study and the Netherlands Cancer Registry
por: van der Willik, Kimberly D., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j6nopjerbbdu5f37rquncafg92